# Implementation status — 6 October 2026

| Phase | Source implementation | Execution validation |
|---|---|---|
| P0 | Package/environment bootstrap and documentation | Package dependencies installed; application run deferred |
| P1 | Event schemas, hash chain, replay, branches | Deferred |
| P2 | Templates, checks and gates | Deferred |
| P3 | Project registration, inventory, environment and runtime helpers | Deferred |
| P4 | Static checks, subprocess execution, sandbox and vault | Deferred |
| P5 | Providers, structured responses, usage, egress and budgets | Deferred |
| P6 | Roles, turn loop, Session API, CLI and script verification | Deferred |
| P7 | Textual interface, reports, Inspector and text banner | Deferred |
| P8 | Survival template, iteration invalidation, branch/edit safeguards and documentation | Deferred |
| P9 | Not implemented; reserved for later authorization | Not applicable |

Static source lint and formatting are performed separately from runtime verification. Tests and test
fixtures have not been added or run because the author explicitly deferred them. No live calls, smoke
runs, golden anemia/survival run, full-cycle run or UI interaction test has been performed. The original
anemia data will be supplied later; no absolute anemia path is embedded in application source.

Open author choices: license, scientific template content, package/repository names, default models,
image logo, later provider/account access and optional P9 features. Defaults from plan.md remain intact.

Next authorized validation should cover log corruption/concurrent writes, branch replay, stale checks,
custom scope rejection, namespace mount denial, test plaintext lifecycle, fit/index evidence, provider
error accounting, report reconstruction, UI navigation and complete synthetic/offline workflows.
Then use the supplied anemia data and configured providers for explicitly approved live runs. This
file describes implementation status; it does not claim the plan's acceptance checks have passed.
